Hiroyuki Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroyuki Suzuki has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Michihiko Goto
Center for Access & Delivery Research & Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa
7 shared publicationsBruce Alexander
Center for Access and Delivery Research & Evaluation (CADRE), Iowa City Veterans’ Affairs Health Care System, Iowa City, Iowa
6 shared publicationsDaniel J. Livorsi
Center for Access & Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, IA
6 shared publicationsEli N. Perencevich
Center for Access & Delivery Research & Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA
6 shared publicationsRajeshwari Nair
University of Iowa
5 shared publicationsDaniel J Livorsi
Center for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System , Iowa City, Iowa , USA
4 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e309
Antibiotic prescribing trends and outcomes in outpatient low-risk diverticulitis: a retrospective analysis in Veterans Health Administration between 2016 and 2023
Background: Outpatient antibiotic prescribing remains common despite evidence that selective non-antibiotic management is safe for low-risk uncomplicated diverticulitis. Although recent guidelines recommend withholding antibiotics in selected patients, real-world prescribing patterns and associated outcomes remain unclear. Methods: We conducted a retrospective cohort study using nationwide Veterans Health Administration data (2016–2023) to identify emergency department visits for a first case of uncomplicated diverticulitis among patients discharged without admission. Low-risk diverticulitis was defined as age 3 /µL. Outcomes included antibiotic prescribing trends, assessed using linear regression, and one-year hospitalization for diverticulitis. Analyses for one-year hospitalization were stratified by age and comorbidity burden to assess effect modification. Subdistribution hazard (Fine-Gray) models estimated adjusted hazard ratios, accounting for the competing risk of death. Results: Among 4,249 patients with low-risk diverticulitis (median age, 51 yr; 84.6% male), 4,068 (95.7%) received antibiotics. From 2016 to 2023, the proportion managed without antibiotics remained unchanged (approximately 4%), while β-lactam use increased and fluoroquinolone use declined. Antibiotic use was not significantly associated with a reduced risk of one-year hospitalization (adjusted hazard ratio, 0.99; 95% confidence interval, 0.54–1.84; P = .99). No significant differences were observed across age-comorbidity strata or antibiotic classes, although subgroup analyses may have been underpowered. Conclusions: Despite guideline recommendations, antibiotics were prescribed for most low-risk patients with uncomplicated diverticulitis, with no change over eight years. Clinical outcomes did not differ by antibiotic exposure, highlighting an opportunity to reduce unnecessary antibiotic use through outpatient stewardship interventions.
- 1 October 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e309
Open AccessAntibiotic prescribing trends and outcomes in outpatient low-risk diverticulitis: a retrospective analysis in Veterans Health Administration between 2016 and 2023
Background: Outpatient antibiotic prescribing remains common despite evidence that selective non-antibiotic management is safe for low-risk uncomplicated diverticulitis. Although recent guidelines recommend withholding antibiotics in selected patients, real-world prescribing patterns and associated outcomes remain unclear. Methods: We conducted a retrospective cohort study using nationwide Veterans Health Administration data (2016–2023) to identify emergency department visits for a first case of uncomplicated diverticulitis among patients discharged without admission. Low-risk diverticulitis was defined as age 3 /µL. Outcomes included antibiotic prescribing trends, assessed using linear regression, and one-year hospitalization for diverticulitis. Analyses for one-year hospitalization were stratified by age and comorbidity burden to assess effect modification. Subdistribution hazard (Fine-Gray) models estimated adjusted hazard ratios, accounting for the competing risk of death. Results: Among 4,249 patients with low-risk diverticulitis (median age, 51 yr; 84.6% male), 4,068 (95.7%) received antibiotics. From 2016 to 2023, the proportion managed without antibiotics remained unchanged (approximately 4%), while β-lactam use increased and fluoroquinolone use declined. Antibiotic use was not significantly associated with a reduced risk of one-year hospitalization (adjusted hazard ratio, 0.99; 95% confidence interval, 0.54–1.84; P = .99). No significant differences were observed across age-comorbidity strata or antibiotic classes, although subgroup analyses may have been underpowered. Conclusions: Despite guideline recommendations, antibiotics were prescribed for most low-risk patients with uncomplicated diverticulitis, with no change over eight years. Clinical outcomes did not differ by antibiotic exposure, highlighting an opportunity to reduce unnecessary antibiotic use through outpatient stewardship interventions.
- Open Access
- 8 September 2026
- Published by Wiley in International Wound Journal
- Vol. 23 (9) , e71039
Changing Patterns of Specialty Care for Diabetic Foot Ulcers Among Rural and Urban Veterans Following the VA MISSION Act
The Veterans Affairs (VA) Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act expanded eligibility for community‐based care particularly for Veterans facing geographic or capacity‐related barriers. Patients with diabetic foot ulcers (DFU) require timely specialty management and are vulnerable to fragmented care, yet little is known about how the MISSION Act reshaped patterns of DFU‐related specialty care within and outside the VA. We conducted a retrospective cohort study of Veterans aged 65 or older with a new DFU diagnosis in VA between 2016 and 2022. We identified DFU‐related specialty encounters (podiatry, vascular surgery, infectious diseases and endocrinology) and categorised community encounters as VA‐paid or Medicare‐paid. We assessed annual trends in community specialty care and changes in the proportion and payer type of care before and after the MISSION Act. Among 76 398 patients, VA‐paid community specialty care increased substantially following the MISSION Act, with larger relative growth among rural Veterans (rural: +119%; urban: +96%). In contrast, Medicare‐paid DFU specialty care declined during the same period (rural: −12%; urban: −13%). Following the MISSION Act, reliance on VA‐paid community specialty care increased markedly for Veterans with DFU, particularly in rural areas, while reliance on Medicare‐paid care decreased.
- 8 September 2026
- Published by Wiley in International Wound Journal
- Vol. 23 (9) , e71039
Open AccessChanging Patterns of Specialty Care for Diabetic Foot Ulcers Among Rural and Urban Veterans Following the VA MISSION Act
The Veterans Affairs (VA) Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act expanded eligibility for community‐based care particularly for Veterans facing geographic or capacity‐related barriers. Patients with diabetic foot ulcers (DFU) require timely specialty management and are vulnerable to fragmented care, yet little is known about how the MISSION Act reshaped patterns of DFU‐related specialty care within and outside the VA. We conducted a retrospective cohort study of Veterans aged 65 or older with a new DFU diagnosis in VA between 2016 and 2022. We identified DFU‐related specialty encounters (podiatry, vascular surgery, infectious diseases and endocrinology) and categorised community encounters as VA‐paid or Medicare‐paid. We assessed annual trends in community specialty care and changes in the proportion and payer type of care before and after the MISSION Act. Among 76 398 patients, VA‐paid community specialty care increased substantially following the MISSION Act, with larger relative growth among rural Veterans (rural: +119%; urban: +96%). In contrast, Medicare‐paid DFU specialty care declined during the same period (rural: −12%; urban: −13%). Following the MISSION Act, reliance on VA‐paid community specialty care increased markedly for Veterans with DFU, particularly in rural areas, while reliance on Medicare‐paid care decreased.
- 1 September 2026
- Published by Clinical Care Targeted Communications Group, LLC in The American Journal of Managed Care
- Vol. 32 (9) , e309-e315
Community Care Consultations for Veterans with Diabetic Foot Ulcers
These findings demonstrate substantial but variable use of community care consultations for specialty care among patients with diabetic foot ulcers within the Veterans Health Administration.
- 1 September 2026
- Published by Clinical Care Targeted Communications Group, LLC in The American Journal of Managed Care
- Vol. 32 (9) , e309-e315
Community Care Consultations for Veterans with Diabetic Foot Ulcers
These findings demonstrate substantial but variable use of community care consultations for specialty care among patients with diabetic foot ulcers within the Veterans Health Administration.
- 22 June 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 131, 319-326
Underutilization of an Objective Vascular Screening Test in Patients with Diabetic Foot Ulcers
- 22 June 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 131, 319-326
Underutilization of an Objective Vascular Screening Test in Patients with Diabetic Foot Ulcers
- Open Access
- 23 February 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e52
Associations between suppressive antibiotic therapy, treatment failure, and side effects among young, immunocompetent veterans with prosthetic joint infection who undergo debridement, antibiotics, and implant retention
Objective: Suppressive antibiotic therapy (SAT) is used to prevent recurrent prosthetic joint infections (PJI) among patients who undergo debridement, antibiotics, and implant retention (DAIR). We aimed to assess SAT outcomes among younger, immunocompetent patients. Design: Retrospective cohort study. Patients: Immunocompetent patients C. difficile infection (aHR: 3.47; 95% CI: 1.38, 8.74). Short-term SAT (aHR: 7.83; 95% CI: 4.80, 12.77) and long-term SAT (aHR: 1.68; 95% CI: 1.19, 2.38) were significantly associated with antibiotic-associated diarrhea. Long-term SAT was not significantly associated with TF alone (aHR = 0.61; 95% CI: 0.32, 1.16). Conclusions: SAT was significantly associated with decreased death or TF and increased side effects. Benefits and risks must be weighed before prescribing SAT to younger, immunocompetent patients.
- 23 February 2026
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 6 (1) , e52
Open AccessAssociations between suppressive antibiotic therapy, treatment failure, and side effects among young, immunocompetent veterans with prosthetic joint infection who undergo debridement, antibiotics, and implant retention
Objective: Suppressive antibiotic therapy (SAT) is used to prevent recurrent prosthetic joint infections (PJI) among patients who undergo debridement, antibiotics, and implant retention (DAIR). We aimed to assess SAT outcomes among younger, immunocompetent patients. Design: Retrospective cohort study. Patients: Immunocompetent patients C. difficile infection (aHR: 3.47; 95% CI: 1.38, 8.74). Short-term SAT (aHR: 7.83; 95% CI: 4.80, 12.77) and long-term SAT (aHR: 1.68; 95% CI: 1.19, 2.38) were significantly associated with antibiotic-associated diarrhea. Long-term SAT was not significantly associated with TF alone (aHR = 0.61; 95% CI: 0.32, 1.16). Conclusions: SAT was significantly associated with decreased death or TF and increased side effects. Benefits and risks must be weighed before prescribing SAT to younger, immunocompetent patients.
- 27 July 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 64 (2) , 28-31
Minocycline-induced lupus
Antibiotics are indicated for inappropriately prolonged durations not only for infectious diseases but also for non-infectious dermatologic conditions such as acne vulgaris, but inappropriate use is not uncommon. Inappropriate antibiotic prescription can contribute to the emergence of multidrug-resistant organisms, patient harm such as adverse drug events and increased healthcare costs. We experienced a case involving a late adolescent with acne vulgaris who had been treated with minocycline for more than 2 years, leading to the development of drug-induced lupus, attributed to minocycline. This resulted in multiple clinic and emergency department visits and extensive and expensive workups, including an invasive procedure. A collaboration between antibiotic stewardship activities and patient-centred medication reviews, followed by personalised deprescribing, could effectively mitigate inappropriate antibiotic prescriptions for non-infectious dermatologic conditions.
- 27 July 2025
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 64 (2) , 28-31
Minocycline-induced lupus
Antibiotics are indicated for inappropriately prolonged durations not only for infectious diseases but also for non-infectious dermatologic conditions such as acne vulgaris, but inappropriate use is not uncommon. Inappropriate antibiotic prescription can contribute to the emergence of multidrug-resistant organisms, patient harm such as adverse drug events and increased healthcare costs. We experienced a case involving a late adolescent with acne vulgaris who had been treated with minocycline for more than 2 years, leading to the development of drug-induced lupus, attributed to minocycline. This resulted in multiple clinic and emergency department visits and extensive and expensive workups, including an invasive procedure. A collaboration between antibiotic stewardship activities and patient-centred medication reviews, followed by personalised deprescribing, could effectively mitigate inappropriate antibiotic prescriptions for non-infectious dermatologic conditions.
- 23 April 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Too Much Coffee: A Rare Cause of Sore Throat
- 23 April 2025
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Too Much Coffee: A Rare Cause of Sore Throat
- Open Access
- 1 April 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (4) , e256781
Facility-Level Variation in Major Leg Amputation Among Patients With Newly Diagnosed Diabetic Foot Ulcer
Importance: The prevalence of diabetes is increasing over time, fueling an epidemic of diabetic foot ulcers (DFUs) and subsequent risk of leg amputation. However, little is known about the variation in outcomes for patients with DFUs according to the health care facilities treating them.Objective: To examine facility-level variation in major leg amputation among veterans with incident DFUs using the Veterans Health Administration (VHA) cohort.Design, Setting, and Participants: A retrospective cohort study was conducted from January 1, 2016, to December 31, 2021, of all veterans with a new diagnosis of DFU at 140 VHA facilities across the US. Patients were followed up to 1 year from DFU diagnosis. Analyses were conducted between March 22, 2024, and January 13, 2025.Exposure: A facility was assigned to each patient corresponding to the health care site where the initial DFU diagnosis was made.Main Outcomes and Measures: The primary outcome was major leg amputation during the follow-up period. A multivariable mixed-effects regression model with random facility intercepts was applied to assess variation in major leg amputation rates across facilities, adjusting for social drivers of health, comorbidities, and complicated DFU at initial diagnosis. The median odds ratio (MOR) was calculated to quantify facility-level variation in outcomes.Results: A total of 86 094 veterans (98.3% male; mean [SD] age, 73.0 [8.1] years; age range, 55-102 years) were included. Major leg amputation was performed for 3279 veterans (3.8%) within a year of DFU diagnosis. The MOR for facility-level variation in major leg amputation was 1.85, indicating that the odds of major leg amputation were 1.85 times higher between 2 randomly selected facilities for an average patient (P < .001). In contrast, the MOR for facility-level variation in 1-year mortality was 1.16 (P < .001).Conclusions and Relevance: This cohort study of veterans with newly diagnosed DFU found significant facility-level variation in major leg amputation rates within 1 year of DFU diagnosis. Facility-level variation in 1-year mortality rates was much smaller, suggesting variation in leg amputation was likely to stem from variation in DFU-specific care. The VHA should strive to minimize the odds of major leg amputation and interfacility variation.
- 1 April 2025
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 8 (4) , e256781
Open AccessFacility-Level Variation in Major Leg Amputation Among Patients With Newly Diagnosed Diabetic Foot Ulcer
Importance: The prevalence of diabetes is increasing over time, fueling an epidemic of diabetic foot ulcers (DFUs) and subsequent risk of leg amputation. However, little is known about the variation in outcomes for patients with DFUs according to the health care facilities treating them.Objective: To examine facility-level variation in major leg amputation among veterans with incident DFUs using the Veterans Health Administration (VHA) cohort.Design, Setting, and Participants: A retrospective cohort study was conducted from January 1, 2016, to December 31, 2021, of all veterans with a new diagnosis of DFU at 140 VHA facilities across the US. Patients were followed up to 1 year from DFU diagnosis. Analyses were conducted between March 22, 2024, and January 13, 2025.Exposure: A facility was assigned to each patient corresponding to the health care site where the initial DFU diagnosis was made.Main Outcomes and Measures: The primary outcome was major leg amputation during the follow-up period. A multivariable mixed-effects regression model with random facility intercepts was applied to assess variation in major leg amputation rates across facilities, adjusting for social drivers of health, comorbidities, and complicated DFU at initial diagnosis. The median odds ratio (MOR) was calculated to quantify facility-level variation in outcomes.Results: A total of 86 094 veterans (98.3% male; mean [SD] age, 73.0 [8.1] years; age range, 55-102 years) were included. Major leg amputation was performed for 3279 veterans (3.8%) within a year of DFU diagnosis. The MOR for facility-level variation in major leg amputation was 1.85, indicating that the odds of major leg amputation were 1.85 times higher between 2 randomly selected facilities for an average patient (P < .001). In contrast, the MOR for facility-level variation in 1-year mortality was 1.16 (P < .001).Conclusions and Relevance: This cohort study of veterans with newly diagnosed DFU found significant facility-level variation in major leg amputation rates within 1 year of DFU diagnosis. Facility-level variation in 1-year mortality rates was much smaller, suggesting variation in leg amputation was likely to stem from variation in DFU-specific care. The VHA should strive to minimize the odds of major leg amputation and interfacility variation.
- 18 December 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (12) , e262755
Minocycline-induced lupus
Antibiotics are indicated for inappropriately prolonged durations not only for infectious diseases but also for non-infectious dermatologic conditions such as acne vulgaris, but inappropriate use is not uncommon. Inappropriate antibiotic prescription can contribute to the emergence of multidrug-resistant organisms, patient harm such as adverse drug events and increased healthcare costs. We experienced a case involving a late adolescent with acne vulgaris who had been treated with minocycline for more than 2 years, leading to the development of drug-induced lupus, attributed to minocycline. This resulted in multiple clinic and emergency department visits and extensive and expensive workups, including an invasive procedure. A collaboration between antibiotic stewardship activities and patient-centred medication reviews, followed by personalised deprescribing, could effectively mitigate inappropriate antibiotic prescriptions for non-infectious dermatologic conditions.
- 18 December 2024
- Published by BMJ in BMJ Case Reports
- Vol. 17 (12) , e262755
Minocycline-induced lupus
Antibiotics are indicated for inappropriately prolonged durations not only for infectious diseases but also for non-infectious dermatologic conditions such as acne vulgaris, but inappropriate use is not uncommon. Inappropriate antibiotic prescription can contribute to the emergence of multidrug-resistant organisms, patient harm such as adverse drug events and increased healthcare costs. We experienced a case involving a late adolescent with acne vulgaris who had been treated with minocycline for more than 2 years, leading to the development of drug-induced lupus, attributed to minocycline. This resulted in multiple clinic and emergency department visits and extensive and expensive workups, including an invasive procedure. A collaboration between antibiotic stewardship activities and patient-centred medication reviews, followed by personalised deprescribing, could effectively mitigate inappropriate antibiotic prescriptions for non-infectious dermatologic conditions.
- 23 October 2024
- Published by Springer Nature in Infection
- Vol. 53 (2) , 607-614
Association between adjunctive rifampin and gentamicin use and outcomes for patients with staphylococcal prosthetic valve endocarditis: a propensity-score adjusted retrospective cohort study
Purpose Although guidelines recommend adjunctive rifampin and gentamicin use for patients with staphylococcal prosthetic valve endocarditis (PVE), evidence behind the recommendation is limited and conflicting. Methods We performed a retrospective cohort study of all patients with staphylococcal PVE within the Veterans Health Administration during 2003–2021. Patients were identified with diagnostic codes for prosthetic valves and positive blood cultures for Staphylococcus species and confirmed via manual chart reviews. The primary outcome was the composite of all-cause mortality or recurrence of staphylococcal PVE within one year from diagnosis. Inverse probability of treatment weighting (IPTW) was used to estimate the probability of individuals receiving rifampin using propensity scores. IPTW-adjusted multivariable Cox regression analysis was used to compare outcomes between patients who received rifampin and gentamicin, and those did not. Results Among 373 patients with staphylococcal PVE, 275 (73.7%) and 225 (60.3%) received at least one dose of rifampin and gentamicin, respectively. The incidence of staphylococcal PVE increased from 0.47 (2003-11) to 0.77 (2012-21) per 10,000 hospitalizations. Gentamicin use declined over time (70.1% in 2003–2011 to 54.8% in 2012–2021, p = 0.04) while rifampin use did not change significantly (76.1% in 2003–2011 to 72.4% in 2012–2021, p = 0.43). The composite outcome was observed in 209 (56.0%). Neither rifampin use (adjusted hazard ratio [HR] 0.77, 95% CI 0.48–1.24) and gentamicin use (adjusted HR 1.11, 95% CI 0.71–1.74) was associated with the composite outcome. Conclusion No significant association was observed between adjunctive rifampin or gentamicin use and improved outcomes.
- 23 October 2024
- Published by Springer Nature in Infection
- Vol. 53 (2) , 607-614
Association between adjunctive rifampin and gentamicin use and outcomes for patients with staphylococcal prosthetic valve endocarditis: a propensity-score adjusted retrospective cohort study
Purpose Although guidelines recommend adjunctive rifampin and gentamicin use for patients with staphylococcal prosthetic valve endocarditis (PVE), evidence behind the recommendation is limited and conflicting. Methods We performed a retrospective cohort study of all patients with staphylococcal PVE within the Veterans Health Administration during 2003–2021. Patients were identified with diagnostic codes for prosthetic valves and positive blood cultures for Staphylococcus species and confirmed via manual chart reviews. The primary outcome was the composite of all-cause mortality or recurrence of staphylococcal PVE within one year from diagnosis. Inverse probability of treatment weighting (IPTW) was used to estimate the probability of individuals receiving rifampin using propensity scores. IPTW-adjusted multivariable Cox regression analysis was used to compare outcomes between patients who received rifampin and gentamicin, and those did not. Results Among 373 patients with staphylococcal PVE, 275 (73.7%) and 225 (60.3%) received at least one dose of rifampin and gentamicin, respectively. The incidence of staphylococcal PVE increased from 0.47 (2003-11) to 0.77 (2012-21) per 10,000 hospitalizations. Gentamicin use declined over time (70.1% in 2003–2011 to 54.8% in 2012–2021, p = 0.04) while rifampin use did not change significantly (76.1% in 2003–2011 to 72.4% in 2012–2021, p = 0.43). The composite outcome was observed in 209 (56.0%). Neither rifampin use (adjusted hazard ratio [HR] 0.77, 95% CI 0.48–1.24) and gentamicin use (adjusted HR 1.11, 95% CI 0.71–1.74) was associated with the composite outcome. Conclusion No significant association was observed between adjunctive rifampin or gentamicin use and improved outcomes.